AccueilGroupesDiscussionsPlusTendances
Site de recherche
Ce site utilise des cookies pour fournir nos services, optimiser les performances, pour les analyses, et (si vous n'êtes pas connecté) pour les publicités. En utilisant Librarything, vous reconnaissez avoir lu et compris nos conditions générales d'utilisation et de services. Votre utilisation du site et de ses services vaut acceptation de ces conditions et termes.

Résultats trouvés sur Google Books

Cliquer sur une vignette pour aller sur Google Books.

Chargement...

The Death of Cancer: After Fifty Years on the Front Lines of Medicine a Pioneering Oncologist Reveals Why the War on Cancer Is Winnable and How We Can Get There

par Vincent T. DeVita, Jr., Elizabeth DeVita-Raeburn

MembresCritiquesPopularitéÉvaluation moyenneDiscussions
943288,002 (4.69)Aucun
"The true story of the war on cancer from one of its generals In The Death of Cancer, Dr. Vincent T. DeVita Jr.--former director of the National Cancer Institute, former physician-in-chief at Memorial Sloan Kettering, director of the Yale Cancer Center, former president of the American Cancer Society, and developer of the first successful chemotherapy treatment for Hodgkin's lymphoma, which first demonstrated that advanced cancers of a major organ system in adults could be cured by chemotherapy--provides a personal history of one of the greatest science stories of our time, covering our fight against cancer from a man who's seen it all. But this is more than a history; it's also a work of advocacy. Despite declining mortality rates, DeVita argues, America's cancer patients are being shortchanged by timid doctors, misguided national agendas, and compromised bureaucracies. He gives readers an eye-opening look at the strengths and weaknesses of America's most prestigious cancer centers, showing how patients can use this information to their advantage. Though we're rapidly approaching total victory over cancer, he contends, we need to do more to synthesize our progress and help doctors put it into practice. This is an ambitious book about a life-or-death subject, a vital entry into the cancer literature genre. With historical depth and authenticity, DeVita brings important information to readers about what cancer is, how best to fight it, and what we still have to learn"-- "A personal history of the war on cancer, told by the pioneering oncologist who developed the first successful chemotherapy treatment for Hodgkin's lymphoma"--… (plus d'informations)
Aucun
Chargement...

Inscrivez-vous à LibraryThing pour découvrir si vous aimerez ce livre

Actuellement, il n'y a pas de discussions au sujet de ce livre.

3 sur 3
A fascinating book that is part memoir and part history of the treatment of cancer from the 1940’s to the present. Devita was a medical student during the infancy of chemotherapy, and subsequently developed the first successful chemotherapy treatment for Hodgkin’s lymphoma. A fascinating story of someone in the trenches advocating for his patients and working tirelessly for cures. ( )
  St.CroixSue | May 18, 2016 |
Despite being a little dry reading in parts, this is an exceptional behind-the-scenes look at the War on Cancer by one who fought in its trenches. It is a book that looks at where we came from, where we are now and looks to a promising future if we simply fund and allow cancer researchers to do what they do best. This is a book for our legislators and those in the FDA to read and understand so they can assist in this effort, as well as a book for everyone concerned about cancer. I have gained tremendous insights into what cancer is and why there is hope for a better outcome every day. ( )
  Susan.Macura | Jan 31, 2016 |
As a young doctor working at the NIH in the early 1960s, Dr. DeVita came under the influence of Tom Frei and Jay Freireich, who were pushing the boundaries of multiple drug chemotherapy to fight cancer. Freireich's "never give up" approach burned deeply into DeVita's mind. DeVita applied the multiple drug approach used against leukemia to lymphoma, and achieved results that he described as "curing" cancer in many of his patients, to the distress of others in the oncology field. Always an optimist, DeVita was always on the lookout for approaches that would extend the lives of his patients, in the hope that the state of medicine would bring forth new treatment options. He was often correct, although the treatment options often were extremely difficult to access, due to regulatory barriers. DeVita rails against those barriers, especially the ones erected by the FDA, arguing that the rules for drugs for near-death cancer patients should differ from those applied to chronic diseases such as arthritis or diabetes. DeVita also attacks cancer surgeons and radiologists as being slow to pick up on the newest treatment options -- such as adjuvant chemotherapy in conjunction with breast cancer surgery -- and suggests that part of the motivation may have been financial. All cancer patients would want a doctor like DeVita fighting for them -- a doctor who knows which cancer centers have the most advanced treatment approaches for the specific cancers they have, and also is savvy enough to figure out how to get admission to the promising but not yet FDA-approved treatments. ( )
  pheinrich | Jan 30, 2016 |
3 sur 3
aucune critique | ajouter une critique

» Ajouter d'autres auteur(e)s

Nom de l'auteurRôleType d'auteurŒuvre ?Statut
DeVita, Vincent T., Jr.auteur principaltoutes les éditionsconfirmé
DeVita-Raeburn, Elizabethauteur principaltoutes les éditionsconfirmé
Vous devez vous identifier pour modifier le Partage des connaissances.
Pour plus d'aide, voir la page Aide sur le Partage des connaissances [en anglais].
Titre canonique
Informations provenant du Partage des connaissances anglais. Modifiez pour passer à votre langue.
Titre original
Titres alternatifs
Date de première publication
Personnes ou personnages
Lieux importants
Évènements importants
Films connexes
Épigraphe
Dédicace
Premiers mots
Citations
Derniers mots
Notice de désambigüisation
Directeur de publication
Courtes éloges de critiques
Informations provenant du Partage des connaissances anglais. Modifiez pour passer à votre langue.
Langue d'origine
DDC/MDS canonique
LCC canonique

Références à cette œuvre sur des ressources externes.

Wikipédia en anglais

Aucun

"The true story of the war on cancer from one of its generals In The Death of Cancer, Dr. Vincent T. DeVita Jr.--former director of the National Cancer Institute, former physician-in-chief at Memorial Sloan Kettering, director of the Yale Cancer Center, former president of the American Cancer Society, and developer of the first successful chemotherapy treatment for Hodgkin's lymphoma, which first demonstrated that advanced cancers of a major organ system in adults could be cured by chemotherapy--provides a personal history of one of the greatest science stories of our time, covering our fight against cancer from a man who's seen it all. But this is more than a history; it's also a work of advocacy. Despite declining mortality rates, DeVita argues, America's cancer patients are being shortchanged by timid doctors, misguided national agendas, and compromised bureaucracies. He gives readers an eye-opening look at the strengths and weaknesses of America's most prestigious cancer centers, showing how patients can use this information to their advantage. Though we're rapidly approaching total victory over cancer, he contends, we need to do more to synthesize our progress and help doctors put it into practice. This is an ambitious book about a life-or-death subject, a vital entry into the cancer literature genre. With historical depth and authenticity, DeVita brings important information to readers about what cancer is, how best to fight it, and what we still have to learn"-- "A personal history of the war on cancer, told by the pioneering oncologist who developed the first successful chemotherapy treatment for Hodgkin's lymphoma"--

Aucune description trouvée dans une bibliothèque

Description du livre
Résumé sous forme de haïku

Discussion en cours

Aucun

Couvertures populaires

Vos raccourcis

Évaluation

Moyenne: (4.69)
0.5
1
1.5
2
2.5
3
3.5
4 2
4.5 1
5 5

Est-ce vous ?

Devenez un(e) auteur LibraryThing.

 

À propos | Contact | LibraryThing.com | Respect de la vie privée et règles d'utilisation | Aide/FAQ | Blog | Boutique | APIs | TinyCat | Bibliothèques historiques | Critiques en avant-première | Partage des connaissances | 204,809,710 livres! | Barre supérieure: Toujours visible